Page 62 - 《中国药房》2023年22期
P. 62

干预效果与阳性对照药相当。这表明 IRN 可通过抑制                               phage infiltration[J]. Oxid Med Cell Longev,2020,2020:
          气道炎症反应来发挥改善哮喘的作用,与文献调研结果                                 1936580.
          基本吻合,但其作用机制仍需深入探索。                                  [ 7 ]  HUANG X,YU H,XIE C,et al. Louki zupa decoction at‐
              趋化因子是一类能诱导反应细胞定向趋化的细胞                                tenuates the airway inflammation in acute asthma mice in‐
                                                                   duced by ovalbuminthrough IL-33/ST2-NF-κB/GSK3β/
          因子,能引导表达趋化因子受体的细胞迁移到局部趋化
                                                                   mTOR signalling pathway[J]. Pharm Biol,2022,60(1):
          因子配体浓度高的位点,从而导致炎症反应。作为趋化
          因子家族的成员,MCP-1(又称CCL2)与其受体CCR2参                           1520-1532.
                                             [14]
          与了多种炎症和神经退行性疾病的发生 。研究表明,                            [ 8 ]  李秀茹,张毅,李凤,等. 金莲花胶囊对卵清蛋白诱导的
                                                                   过敏性哮喘小鼠气道炎症的作用研究[J]. 扬州大学学报
          CCL2 与哮喘儿童的炎症反应密切相关,研究其相关机                              (农业与生命科学版),2023,44(2):39-46.
                                                       [15]
          制可为儿童特应性哮喘的诊断标志物挖掘提供方向 。                                 LI X R,ZHANG Y,LI F,et al. Effects of Jinlianhua cap‐
          本研究发现,哮喘小鼠肺组织中MCP-1、CCR2蛋白表达                             sules on airway inflammation in ovalbumin-induced aller‐
          水平均显著升高,提示哮喘发生可能与MCP-1/CCR2信                             gic asthma mice[J]. J Yangzhou Univ Agric Life Sci Ed,
          号通路激活有关;经 IRN 干预后,MCP-1、CCR2 蛋白表                         2023,44(2):39-46.
          达水平均显著降低,哮喘小鼠的炎症反应也显著减弱,                            [ 9 ]  陈晓,李泽朋,何晓伟,等 . 异钩藤碱调控 ERK/p27 信
                                                                                                          Kip1
          病理损伤也得到改善,推测 IRN 可能通过抑制 MCP-1/                           号通路改善博莱霉素诱导的小鼠肺纤维化[J]. 天然产物
          CCR2信号通路的激活来减轻哮喘小鼠的气道炎症。为                                研究与开发,2022,34(5):750-760.
          证明上述推测,本研究以MCP-1/CCR2信号通路激活剂                             CHEN X,LI Z P,HE X W,et al. Isorhynchophylline alle‐
          CCL2 进行验证,结果发现,CCL2 逆转了高剂量 IRN 对                         viates  bleomycin-induced  pulmonary  fibrosis  by  regula-
                                                                             Kip1
          哮喘小鼠的保护作用,表明IRN对哮喘小鼠的气道炎症                                ting  ERK/p27   signaling  pathway  in  mice[J].  Nat  Prod
                                                                   Res Dev,2022,34(5):750-760.
          具有抑制作用,可能与抑制MCP-1/CCR2信号通路的激
                                                              [10]  龙江宜,陈健民,廖苑君,等 . 柚皮苷改善 CCL2 所致大
          活有关。
                                                                   鼠学习记忆障碍及其机制[J]. 中国药理学通报,2020,36
              综上所述,IRN 可能通过抑制 MCP-1/CCR2 信号通
                                                                  (3):372-379.
          路的激活来减少哮喘小鼠气道炎症因子的释放,从而达                                 LONG  J Y,CHEN  J  M,LIAO Y  J,et  al.  Naringin  im‐
          到改善哮喘的目的;但由于哮喘发病机制复杂,后续将                                 proves  learning  and  memory  impairment  induced  by
          进一步深入研究。                                                 CCL2 in rats and its mechanism[J]. Chin Pharmacol Bull,
          参考文献                                                     2020,36(3):372-379.
          [ 1 ]  LEE  J  E,IM  D  S.  Suppressive  effect  of  carnosol  on   [11]  WANG J R,GAO S N,ZHANG J Y,et al. Interleukin-22
               ovalbumin-induced  allergic  asthma[J].  Biomol  Ther,  attenuates  allergic  airway  inflammation  in  ovalbumin-
               2021,29(1):58-63.                                   induced asthma mouse model[J]. BMC Pulm Med,2021,
          [ 2 ]  WANG L H,GU Z W,LI J,et al. Isorhynchophylline in‐  21(1):385.
               hibits  inflammatory  responses  in  endothelial  cells  and   [12]  QIU M,YANG Z,BIAN M N,et al. Protective effects of
               macrophages  through  the  NF- κB/NLRP3  signaling  path‐  isorhynchophylline  against  silicon-dioxide-induced  lung
               way[J]. BMC Complement Med Ther,2023,23(1):80.      injury in mice[J]. Artif Cells Nanomed Biotechnol,2020,
          [ 3 ]  WANG C,ZHU M H,SUN N,et al. Isorhynchophylline    48(1):1125-1134.
               ameliorates  stress-induced  emotional  disorder  and  cognitive   [13]  LI H,BI Q Y,CUI H X,et al. Suppression of autophagy
               impairment with modulation of NMDA receptors[J]. Front   through JAK2/STAT3 contributes to the therapeutic action
               Neurosci,2022,16:1071068.                           of rhynchophylline on asthma[J]. BMC Complement Med
          [ 4 ]  ZHU J Y,WANG W Q,WU X. Isorhynchophylline exerts   Ther,2021,21(1):21.
               anti-asthma effects in mice by inhibiting the proliferation   [14]  BAO  X  B,CHEN  C,YUAN  L  Y.  Triptolide  attenuates
               of airway smooth muscle cells:the involvement of miR-  neuropathic  pain  by  regulating  microglia  polarization
               200a-mediated FOXC1/NF-κB pathway[J]. Biochem Bio‐  through the CCL2/CCR2 axis[J]. Evid Based Complement
               phys Res Commun,2020,521(4):1055-1060.              Alternat Med,2021,2021:8985721.
          [ 5 ]  DANSEREAU  M A,MIDAVAINE  É,BÉGIN-LAVALLÉE   [15]  CHEN R,PIAO L Z,LIU L,et al. DNA methylation and
               V,et al. Mechanistic insights into the role of the chemo‐  gene  expression  profiles  to  identify  childhood  atopic
               kine CCL2/CCR2 axis in dorsal root ganglia to peripheral   asthma  associated  genes[J].  BMC  Pulm  Med,2021,21
               inflammation and pain hypersensitivity[J]. J Neuroinflam‐  (1):292.
               mation,2021,18(1):79.                                        (收稿日期:2023-05-15  修回日期:2023-10-20)
          [ 6 ]  LI  T,XIAO  G,TAN  S  P,et  al.  HSF1  attenuates  LPS-                          (编辑:曾海蓉)
               induced acute lung injury in mice by suppressing macro‐





          · 2744 ·    China Pharmacy  2023 Vol. 34  No. 22                            中国药房  2023年第34卷第22期
   57   58   59   60   61   62   63   64   65   66   67